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Summary.-Fibroblast cultures established from the skin of 56 healthy controls and
15 untreated Stages I and II Hodgkin's patients (HD) were studied in their 3rd, 4th
and 5th in vitro passage with respect to transformation with Simian sarcoma virus
(SSV) and SV40 and with respect to replication of herpes simplex virus (HSV)
Types 1 and 2, pox virus and interferon release. Susceptibility to the 5 viruses varied
independently, except for an inverse correlation between susceptibility to SSV and
HSV. HD cultures showed a depressed replication of both types of HSV. There was a
borderline (P=0.02) correlation between magnitude of HSV replication and presence
of HL-A type B-w44, but this does not explain the HD control difference. Further-
more, the level of serum antibodies to HSV common antigen was not related to
magnitude of in vitro replication. The results thus speak against generally enhanced
cellular susceptibility to HSV as a reason for the high titres of serum antibodies to
HSV in HD patients.
HODGKIN'S DISEASE (HD) is associated
with raised titres of serum antibodies to
Epstein-Barr virus (EBV) (Levine et al.,
1971) to herpes simplex virus common
antigen (Hesse et al., 1977) and according
to one publication also to Simian sarcoma
virus gp7O (Ebbesen et al., 1979). The
relationship ofthese virological aberrations
to aetiology and pathogenesis is un-
resolved; they might be primary or
secondary to the changes in immune
functions often detectable in HD, or HD
might be characterized by an abnormal
non-immunological relationship between
virus and cells. The latter possibility was
studied in the present work.
MATERIALS AND METHODS
Biopsies.-A piece of abdominal skin was
obtained from 56 controls, of which 33 were
* Sponsored by the Danislh Cancer Society.
operated on for benign lesions such as large
breast and 23 were completely healthy
donors. The controls were 10-90 years of age
(mean 31). Skin was also obtained from 16
Stages I and II. HD patients during splen-
ectomy for staging purposes. Their age
varied from 8 to 70 years and 6 were classified
as nodular sclerosis, 5 as lymphocyte pre-
dominance and 5 as mixed cellularity. The
biopsies were immediately placed in cold
Eagle's minimum essential medium with
Hanks' balanced salt solution, pH 7-8 (MEM)
with 10% foetal calf serum (FCS), which was
also the medium for all fibroblast cultures.
The biopsies had subcutaneous fat removed
and were cut into pieces measuring '4 mm2,
which were placed in plastic bottles, barely
covered with medium and left undisturbed
for 3 days at 37°C in 5% CO2. Thereafter
change of medium was done thrice weekly
for 3 weeks, before reseeding. All cultures
were tested initially in the 3rd passage, inHD SKIN FIBROBLASTS AND HERPES SIMPLEX VIRUS
which the population doubling time in
exponential phase was 72 h.
Simian sarcoma virus.-Simian sarcoma
virus (SSV) (Theilen et al., 1971) kindly
supplied by Dr Fritz Dienhardt (Rush-
Presbyterian-St Luke's Medical Centre, De-
partment of Microbiology, Chicago, Illinois,
U.S.A.) was cloned and harvested once from
infected normal human skin fibroblasts,
filtered (450 nm) and frozen. The titre in
cells from person No. 53 was 5 x 104 FFU/ml.
A fresh ampoule was used for each test.
Similarly, a fresh vial from a frozen batch of
normal cells from person No. 53 was thawed,
cultured and included in each test. The day
after seeding in small (75cm2) Falcon plastic
flasks, the subconfluent cultures with 105
viable cells were infected. Half the cultures
were pretreated with diethylaminoethyl-
dextran (DEAE, 10 ,ug/ml) for 30 min and
infected with one-tenth of the amount of
virus used without DEAE. The virus doses
used were 10 1ul diluted 1: 10 and 1:40. One-
hit titration curves (transformed foci) were
obtained with the most susceptible as well as
the most resistant cells. All tests were done
in triplicate at least twice.
Herpes simplex virus (HSV) Type 1 and
Type 2.-Strain Macintyre and strain MS
(American Type Culture Collection lot No.
1-D) were propagated in a rabbit cornea cell
line. This cell line also served as cell control
each time human fibroblasts were infected
(Vestergaard et al., 1972). The virus titres
here were 2 x 106 + 105 PFU/ml for Type 1
and 3-6 x 106 + 105 PFU/ml for Type 2. Cells
harvested from the second in vitro passage of
human fibroblasts were seeded in 60mm
Petri dishes. At confluence (5 x 105 cells) the
cultures were infected with 10-fold-dilution
rows (10-1-106) of HSV and overlaid with
maintenance medium containing 2% human
serum with high-titre HSV antibodies for
plaque development. As the same number of
cells was present in each dish, the results
obtained are plaques per 5x 105 cells. For
each test with 6 dilutions the titre was
calculated by the Reed-Muench method.
Rabbit cornea cells were included in each
day's testing.
Serum antibodies to HSV Type 1.-Serum
antibodies to HSV Type 1 were assessed in an
ELISA assay using ion-exchange chromato-
graphically purified antigen from Triton
X-100 solubilized HSV Type 1 infected rabbit
cornea cells (Vestergaard et al., 1977).
SV40 T-antigen assay.-Two different pre-
parations of small-plaque SV40 virus were
used in the present study. They were grown
in CV-1 cells and the titres were 1.5 x 108 and
2 x 108 PFU/ml on CV-1 cells. Fibroblasts
(3-5 x 105) grown overnight in Falcon flasks
were infected for 3 h at 37°C with small-
plaque SV40 virus, at a multiplicity of infec-
tion of about 200. Infected cells were main-
tained in medium (RPMI 1640 with 10%
foetal bovine serum) containing 1% rabbit
anti-SV40 serum. Next day, cells were trans-
ferred to a square Petri dish containing 38-
well printed slides in medium containing
anti-SV40 serum. Forty-eight hours later,
slides were washed with phosphate-buffered
saline, fixed in cold acetone and stained for
T-antigen by the indirect fluorescent-anti-
body method, using hamster T-antibody
(courtesy of Dr K. Takemoto) and fluoro-
scein-conjugated goat anti-hamster globulin.
The number of T-antigen-positive cells in 2
different wells was counted. Cells were then
stained with Giemsa and the total number of
cells in each well was counted. The percentage
of T-antigen-positive cells was then calcu-
lated (Takemoto et al., 1968) and considered
a marker for transformation. CV-1 cells were
included in each day's testing.
Pox virus.-The vaccinia strain used for
public vaccination in Denmark was used.
Confluent cultures were washed x 3 in PBS
and inoculated with 50 haemagglutinating
units of virus. After 30min incubation at
37°C, the cultures were again washed x 3 and
medium was added. The presence or absence
of cytopathic effect was scored after 24, 48
and 95 h. Cells from person 53 were included
in each day's testing.
Statistics.-The titres obtained with the
various viruses (focus- or plaque-forming
units/ml) were used as (inverse) measures of
the susceptibility of the cultures. Correlation
between values obtained with 2 different
viruses was calculated by Spearman's rank
correlation coefficient. Results obtained with
cells from healthy donors were compared
with those from HD cells by the non-para-
metric Mann-Whitney and x2 tests.
Induction of interferon.-All cells used for
induction of interferon were grown in 30ml
culture flasks (Falcon(®)) in MEM supple-
mented with 15% FCS. After confluence, the
cultures were washed and some cultures were
given 5 ml MEM supplemented with 2%
FCS containing Poly I:C (Miles Lab. code
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11-231, lot 8) in different concentrations (i.e.
4 5, 0 5 and 0 05 u/ml). Other cultures were
infected with 4 haemagglutinating units of
Newcastle disease virus (NDV), drained after
2 h, washed with MEM and then given 5 ml
MEM with 2% FCS. All cultures were incu-
bated for 24 h, the medium was then har-
vested, dialysed against S0rensen buffer
(pH 2) for 48 h at 4°C and then dialysed back
to pH 7-4.
Interferon assay.-Determination of the
antiviral activity was performed in cultures
of human fibroblasts (Haahr, 1968). After
growth to confluence in 60mm Petri dishes,
the medium was replaced by 1 ml of 2-fold
serial dilutions ofspecimens to be tested. Each
dilution was tested in two cultures. After
incubation for 6 h, the cultures were chal-
lenged with 50 PFU of vesicular stomatitis
virus (VSV) strain Indiana. The cultures were
drained after a lh absorption and overlaid
with 0.6% agar (DIFCO) in MEM. Neutral
red was added 24 h later and the plaques
were counted. Interferon titres were recorded
as the reciprocal ofthe highest dilution which
reduced the number ofplaques counted in the
controls by 5000. All assays were done x 3.
Testing a stock preparation of interferon was
included in each assay stock. Stock prepara-
tion ofhuman fibroblast interferon was made
by inoculating human skin fibroblast mono-
layers in 250ml Falcon bottles with 4 haem-
agglutinating units ofNDV per cell suspended
in 15 ml of MEM with 2% FCS. The super-
natants were harvested after 24h incubation
and dialysed against pH 2 for 48 h at +4C
and then dialysed back to pH 7-4. The
titre was equivalent to 2000 iu of interferon
per ml.
HL-A typing.-Simultaneously with the
taking of skin biopsy, blood was drawn and
part of it used for determining HL-A type;
the remaining erythrocytes and granulocytes
were removed on a Lymphoprep gradient
(Boyum, 1968) and were then frozen with
15% dimethylsulphoxide in a programmed
freezer (1°C/min). HL-A typing was per-
formed by the method of Kissmeyer-Nielsen
and Kjerbye (1967). Patients and controls
were typed for the following HL-A antigens:
1, 2, 3, 8, 10, 11, 25, 26, 28, 29, w19, w,23,
w24, w30+, w31, and w32 of the A series;
5, 7, 8, 12, 13, 14, 15, 16, 17, 18, 27, 37, 40,
w16, w21, w22, w35, w38, w39, w41, w44,
w45, and w47 of the B series; and wl. w3,
and 24 of the C series.
RESULTS
(1) Testing with our standard virus
batches on our standard cells (person 53)
included in each test gave these mean
titres + s.d. (focus-forming units (FFU),
plaque-forming units (PFU) per ml): SSV
53+24x103 FFU, SSV+DEAE 112+
29x 103 FFU, HSV-1 ]-98+0-83x 106
PFU, HSV-2 3.57 + 13 x 105 PFU, SV40
2.6 + 1.20% stained cells. The interferon
release from the standard cell was 8000
u/ml fluid medium after infection with
NDV.
(2) Most of the results from testing cell
cultures established from healthy persons
are given in Fig. 1. In addition, Poly I:C
gave detectable interferon release from
only 5/40 tested, pox virus caused cyto-
pathic effect within 72 h in 32/37 tested.
Resistant cultures or permissive cultures
remained so on testing 20 cultures during
the 3 subsequent in vitro passages, and
also after storage in liquid N2 (P < 0*01,
x2). From Day 1 to Day 5 after seeding,
the cell population-doubling time was
-72h.
To study the kinetics of the SSV infec-
tion, response curves for 2 persons with
high-permissive and 2 with low-permissive
cultures were made (Fig. 2). There is
some evidence of deviation from one-hit
kinetics at low virus dose with the less
susceptible cells.
SSV titre obtained with and without
pretreatment with DEAE, correlated posi-
tively at the 0 001 level of probability,
and SSV showed negative correlation with
HSV-1 (P < 0 02) (Fig. 3). Apart from this,
no correlation between values for in vitro
test with any 2 viruses, or between in
vitro virus titre and level of antibodies to
HSV in serum, was found, and no correla-
tion with those values and the NDV-
provoked interferon activity (Table).
The titres obtained were also uncorrelated
to HL-A type (P> 0.05), except for an
apparent correlation (P=0.02) between
high susceptibility to HSV-1 and HSV-2
and the presence of the antigen B-w44.
The HD fibroblasts most resistant to
HSV-1 and/or HSV-2 were of the histo-
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FiG. 1.-Foci or plaques obtained by infecting human skin fibroblasts from healthy donors. Units of
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logical subtype lymphocyte predominance
and mixed cellularity (not statistically
significant at the 1% level).
(3) Comparison of virus susceptibility
between fibroblasts from HD patients and
healthy persons was made by calculating
the mean FFU or PFU values obtained
with the standard cells as 100. The mean
values found in fibroblasts from healthy
persons and HD patients were thereafter
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TABLE. Mean in vitro FFU or PFU
obtained with 5 viruses, and interferon
releases after ND virus infection of skin
fibroblacst cultures from normal and HD
patients
Virus
SSV with DEAE
SSV witlhout
DEAE
HSV-I
HSV-l:
SV40
Interferon release
100v=alue obtained
test.
Cells
Normal
HD
Normal
HD
Normal
HD
Normal
HI)
Normal
HD
Noirmal
HD
MIean + s.cl.
64 + 35
84 + 43
89 + 49
119+47
24+ 6
13+ 7
107+32
69 + 20
99 + 57
87+ 55
101 + 6:3
71 + 44
with stani(claid cells in each
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FIG. 2.-Dose-response curves for infection
of lhuman skin fibroblasts from 4 normal
donors with SV40. 6 cultures were made
from each donor for eaeh virus dilution.
10 1il of virus dilution/75 cm2 flask witlh 105
fibroblasts. Vertical bars indicate standard
deviation. ----- susceptible cultures from
donor 1. - susceptible cultures from
donor 2. -- -- non-permissive cultures from
donor 3. .- non-permissive cultures from
donor 4.
expressed inrelation to the standardvalues
obtained on standard cells, as shown in
the Table. It is seen that the mean value
with and without DEAE-dextran pre-
treatment of the cells (100=value with a
standard normal cell whether DEAE-
dextran pretreated or not) was 84 and 100
in HD and 64 and 89 in control cultures.
Also, for SV40 and Vac virus no difference
was discernible (Vaccinia virus caused
cytopathic effect within 72 h in 18/20
HD cultures), but both HSV-1 and HSV-2
gave lower values in HD than in controls
(P < 0 05, Table I). This titre difference
persisted in the 3 subsequent cell passages.
Matching patients and controls according
to age and sex did not change the outcome
of the comparison.
The HL-A antigen frequencies in the
controls correspond to those previously
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established in healthy Danes. No correla-
tion was discernible between HL-A type
and in vitro susceptibility to infection with
any of the viruses tested, or to titre of
serum antibodies to HSV with cells from
HD patients.
DISCUSSION
Resistance to viral infection can operate
by 2 basic mechanisms. First, the resist-
ance may reflect an accelerated immune
response. The second type of resistance
resides in the target cells. It usually per-
sists in tissue culture, though cultured
cells can have a spectrum of sensitivity to
viral infection broader than that of the
organ from which they came (Evans et al.,
1954). However, in vitro studies are the
only possibility for elucidating this aspect
of human resistance.
As we found that cultures from one
healthy individual could be relatively
resistant to one virus and at the same time
fully susceptible to another, no common
non-specific mechanism can beheldrespon-
sible for the differences in susceptibility
among individuals. It is in line with this
fact that growth rate in vitro varied too
little to account for differences in in vitro
susceptibility to virus, and that no corre-
lation to interferonproduction after stimu-
lation with NDV or POLY I:C was
apparent; again, the interferon production
may have a different pattern with each
virus (de Mayer et al., 1974).
Susceptibility to the 5 viruses tested
variedindependently, the exceptions being
the inverse relationship between suscepti-
bility to SSV and susceptibility to HSV-1
and HSV-2, which suggests the possibility
that infection with SSV and HSV partly
depends on mutually exclusive cell charac-
teristics.
The genetic factors that can influence
host-virus interactions are numerous.
One such ofproven relevance in the intact
individual is the Ir genes controlling
specific immune response (Spencer et al.,
1976). Some Ir genes are linked to the
major histocompatibility system; others
are not (Old & Boyse, 1972). But since
neither the blood types nor HL-A types
tested correlated with in vitro suscepti-
bility, the evidence is that expression of
these antigens is not linked to expression
of factors important for in vitro suscepti-
bility. In vitro-grown chick fibroblasts
vary in adsorption of C-type virus (Vogt
& Ishizaki, 1965) whereas the resistance of
mouse fibroblasts to certain C-type viruses
resides in intracellular events (Bassin
et al., 1975) as does cellular resistance to
vesicular stomatitis (Simpson & Obijeski,
1974). Non-permissiveness, of course,
could also reflect true interference from
pre-existing infection of the cells.
HL-A type Al shows increased inci-
dence among healthy persons with recur-
rent herpes labialis (Russell & Schlaut,
1975). Among the 60 persons here tested,
no correlation exists between HL-A type
and titre of antibody to HSV. The link
between HL-A type A and Herpes labialis-
therefore seems to depend upon other
genes than those controlling the humora
immune response to HSV. Cellular im-
munity is believed to be most important
for immune resistance to HSV (Rager-
Zisman & Allison, 1976; Shore et al., 1974).
The lifetime persistence in most adult
humans of high titres of antibodies to
HSV probably results from nearly all
adults being chronic virus carriers. The
adults with persistently low antibody
titres to HSV could therefore be persons
effectively eliminating emerging virus by
their cellular immune response, or they
might have non-permissive cells. Our
results do not support the latter possi-
bility, as no significant correlation between
individual in vitro susceptibility and level
ofantibody to HSV was discernible.
Our finding that cultures from un-
treated Hodgkin's patients are less sus-
ceptible to in vitro infection with HSV
(both Types 1 and 2) than normal cultures
in spite of no significant differences in
susceptibility to SSV, SV40 and Vac,
suggests thatHodgkin's culturesareindeed
characterized by an abnormal relationship
to herpes-type virus, and that the result
does not represent a fortuity in our multi-
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parameter study. As early-passage cul-
tures, not cloned cell lines, were studied
here, we do not know whether the differ-
ence found between HD and controls
reflects characteristics common to most
of an individual's fibroblasts or differences
in proportion of susceptible and non-
susceptible cells. A few cloning experi-
ments were inconclusive on this point.
It is noticeable that most (Levine et al.,
1971; Henderson et al., 1973; Hesse et al.,
1977) but not all (Evans et al., 1978)
studies show elevated titres of serum
antibody to members of the herpes virus
group in HD patients, whereas these
patients have normal titres of antibodies
to influenza (Ebbesen et al., 1979) and
adenovirus (Hesse et al., 1977).
Both the aetiology and pathogenesis of
Hodgkin's disease are unresolved, but it
is usually considered primarily a disease
of the lympho-reticuloendothelial cells,
sometimes with secondary stimulation of
growth of other cell types such as fibro-
blasts (Wahl et al., 1978; Kaplan et al.
1977). If, indeed, the isolated HD fibro-
blasts differ from normal fibroblasts as
indicated by our study, 2 more possi-
bilities arise. Either the changes in the
reticuloendothelial system are secondary
to some (virus induced?) alteration in
fibroblasts, or HD represents the expres-
sion ofpleiotropic regulatory gene changes
which also give the decreased in vitro
susceptibility to herpes virus.
The association of HL-A type with dis-
ease is particularJy pronounced in certain
states with alteied immune reactivity
(Svejgaard et al.,. 1976). Immune regu-
latory Ir genes are in certain cases asso-
ciated more firmlywith diseases thanisthe
HL-A system (Wernet, 1976), but the Ir
genes are themselves closely linked to the
HL-A system. HL-A antigens are pre-
served during in vitro growth of human
fibroblasts (Brautbar et al., 1973). The
number of cases we have studied so far,
however, do not allow conclusion as to
whether in vitro susceptibility of HD
fibroblasts to the virus tested is HL-A
related.
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